Xenetic Biosciences Inc (XBIO)
3.98
+0.16
(+4.19%)
USD |
NASDAQ |
Mar 27, 16:00
3.99
+0.01
(+0.25%)
Pre-Market: 20:00
Xenetic Biosciences Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2017 | -14.15% |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 |
Date | Value |
---|---|
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
November 30, 2013 | |
August 31, 2013 | -23.52% |
May 31, 2013 | 74.81% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Perspective Therapeutics Inc | 38.66% |
Electromed Inc | 77.03% |
Xtant Medical Holdings Inc | 61.29% |
Asensus Surgical Inc | 21.47% |
Myomo Inc | 65.28% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -35.00% |
Return on Assets | -32.43% |
Return on Invested Capital | -35.00% |
Profit Margin (Quarterly) | -174.3% |
Operating Margin (Quarterly) | -186.9% |